Question

A study was conducted comparing the effectiveness of 2 new Antiviral Drugs. NIH3T cells in 48 well tissue culture trays were treated with either Drug A, Drug B, or were untreated Controls. The untreated cells demonstrated a mean cell count of 100 cells/well. Drug A demonstrated a mean cell count of 96 cells/well. Drug B had a mean of 12 cells per well. The SD for both treated cell sets was 1.31. The t-statistic for Drug A was 21, while the t-statistic for Drug B was 466.

Without a p-value, but based on the raw data cell counts and the t-statistics, which drug data suggests a more pronounced chemotherapeutic effect and thus should be subjected to further testing for human toxicity levels?
A.drug A
b. drug B

Answer 1

Drug B demonstrated a stronger chemotherapeutic effect and has a significantly higher t-statistic compared to Drug A, indicating it should be prioritized for further human toxicity testing.

Step-by-step explanation:

Based on the provided data and t-statistics, Drug B suggests a more pronounced chemotherapeutic effect compared to Drug A. The mean cell count in wells treated with Drug B was only 12 cells/well versus the untreated control with 100 cells/well, indicating a strong antiviral capability. Additionally, the very high t-statistic of 466 for Drug B indicates a significant effect difference when compared to the control group. In contrast, Drug A with a mean of 96 cells/well and a lower t-statistic of 21, while still effective, shows a less pronounced effect than Drug B. Therefore, Drug B is the one that should be subjected to further testing for human toxicity levels.